Save 10% off on your first order with coupon code: FIRST

Buy Mounjaro from Canada!

Mounjaro is available in the following doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg.

Disclaimer

Mounjaro from Canada comes in vial form (one-time use) and will be required to be injected with a syringe. The packaging will contain one single-use syringe for every vial ordered. Each vial will last one week.

If you live in DE, TN, FL or the Virgin Islands, you will require a prescription for a syringe included with your Mounjaro prescription.

Mounjaro (Tirzepatide)

MounjaroGENERICBRAND

2.5mg/0.5mL

Prescription Required. Product of Canada. Shipped from Canada. Sourced from Canada

Prescription Required. Product of United Kingdom. Shipped from United Kingdom. Sourced from United Kingdom

This is a refrigerated product. A flat rate of $29.99 express shipping fee will be applied to your order. This product will be shipped out in an insulated styrofoam container with gel and ice packs inside. Parcels are shipped via Canada Post Express.

Pricing for Mounjaro

  • 1 vial - $158.99 (1 week supply)
  • 2 vials - $317.98 (2 weeks supply)
  • 3 vials - $467.79 (3 weeks supply)
  • 4 vials - $623.96 (4 weeks supply)
  • 5 vials -$749.95 (5 weeks supply)
  • 6 vials - $899.94 (6 weeks supply)

New Mounjaro stock availability will be updated every Saturday!

Mounjaro 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg - OUT OF STOCK

Attention (updated February 24, 2024): We are currently out of stock for all strengths of Mounjaro. Please check back on Saturday, March 2, 2024 for updated availability. If you would like to be on our waiting list to be notified when it is available, please fill out the form below. Thank you.

Mounjaro Waiting List

See what our customers have to say about their purchase!

0 0 votes
Rating

Free with your purchase:

Purchase
Guarantee

Lowest Price
Guarantee

Identity Theft
Guarantee

Satisfaction Guarantee

A 30 day guarantee of up to a $1,000 of the purchase price, that you will receive the products/services you ordered, in accordance with the terms of sale.

Price Protection Guarantee

If the store's published price drops within 30 days of the purchase, you can make a claim for up to $100 of the difference.

ID Recovery Assistance

Provides help in the event of identity theft for up to 30 days after a sale, to help allay concerns about the security of your personal information. Up to total of $10,000 worth of specialist services.

Product Information

What is Mounjaro?

Tirzepatide is the active component of Mounjaro that acts as a glucagon-like peptide-1 receptor agonist (GLP-1) and glucose-dependent insulinotropic polypeptide receptor (GIP).

Mounjaro is a colorless to slightly yellow, clear, sterile, preservative-free solution manufactured by Eli Lilly and Company for subcutaneous injection. Mounjaro is available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg solutions for injection in a pre-filled pen.

What is it used for?

Mounjaro is a prescription medicine given to adults with type 2 diabetes mellitus used along with diet and exercise to reduce blood sugar levels when spiking.

How does it work?

Tirzepatide enables albumin binding as it prolongs the half-life of this medication. It can activate glucose-dependent insulinotropic polypeptide receptors (GIP) and glucagon-like peptide-1 receptor agonists (GLP-1). Mounjaro enhances first and second-phase insulin secretion and reduces glucagon levels in a glucose-dependent manner.

How to take it?

Inspect if the pen is not expired or damaged before using. Discard the Mounjaro pen if it contains any particulate manner or discoloration of the solution. The patient can take this medication with or without food. Rotate the injection site of Mounjaro subcutaneously in the stomach area, thighs, and upper arm on the same day each week to avoid skin irritation. Press then wait 10 seconds before removing the pen from the injection site or check if the gray plunger is visible in the pen, indicating if the administration is complete.

Dosage

The recommended starting dose of Mounjaro is 2.5 mg via subcutaneous injection once weekly for four weeks. The doctor may increase the quantity by adding 2.5 mg in the last dose prescribed if needed. The maximum dosage of Mounjaro is 15 mg once a week. Do not abruptly change the dose without the doctor’s supervision.

Side Effects

The most common are nausea, diarrhea, vomiting, indigestion, constipation, decreased appetite, and stomach pain.

Warnings, Precautions, and Contraindications

Mounjaro is contraindicated in patients with a family history of Medullary Thyroid Cancer (MTC) and Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Anaphylaxis and angioedema are reported in patients taking GLP-1 receptor agonists. Advise female patients using contraceptives to switch to a non-oral contraceptive method, as Mounjaro can affect gastric emptying time. The safety of this drug in people less than 18 years old has not been established yet.

Adverse Effect

An increased risk of severe hypoglycemia is seen in patients taking Mounjaro with Insulin or insulin secretagogues. Acute renal injury and worsening of chronic renal failure that may require hemodialysis, temporary worsening of diabetic retinopathy, acute gallbladder diseases such as cholelithiasis or cholecystitis, and pancreatitis are the things to check in patients who are taking Mounjaro or any other GLP-1 receptor agonists.

Storage

The patient can store Mounjaro pens in the refrigerator with temperatures ranging from 36-46°F (2-8°C) until expiration. An unrefrigerated pen at room temperature or 86°F (30°C) is safe to use for up to 21 days. Do not freeze or expose the pen to light.

Disposal

Put the empty or used pen in an FDA-cleared sharps disposal container or heavy-duty plastic after use. Ensure the container is a leak-resistant, puncture-resistant, sealed container labeled to warn of hazardous waste. Follow the community guidelines on how to dispose of full sharps disposal containers. Do not dispose of Mounjaro pens in the household trash. Do not recycle used sharps disposal containers.

About Bison Pharmacy

Bisonpharmacy.com is a Canadian prescription referral service created by a network of experienced pharmacists with the goal of connecting Americans with life-saving medications at affordable prices. We source high-quality brand-name and generic medications from our licensed pharmacy partners and specialize in shipping them seamlessly to your door. To learn more about Bisonpharmacy.com, reach out to one of our experienced pharmacists or team members today!

Mounjaro FAQ

Getting Prescribed Mounjaro

In order to purchase Mounjaro, you must first consult with a licensed U.S. doctor who will evaluate your eligibility for the drug and may write you a prescription accordingly. Some doctors offer online consultations, which means that you might be able to receive an online Mounjaro prescription.

Mounjaro (tirzepatide) is FDA-approved for the treatment of Type 2 Diabetes in adults over the age of 18 in combination with diet and exercise.

Recently, tirzepatide was also FDA-approved for chronic weight management under the name Zepbound. Zepbound is indicated for use in obese patients (BMI over 30) or overweight patients (BMI over 27) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or heart disease.

In order to be eligible for the Mounjaro Savings Card, you must:

  • Be enrolled in a commercial medical insurance plan
  • Be prescribed Mounjaro for its FDA-approved purpose (blood sugar control for Type 2 Diabetes)
  • Not be enrolled in any government-funded healthcare plans

Visit the manufacturer’s page for full eligibility criteria information.

How Mounjaro Works

Mounjaro is a dual-targeted treatment that mimics two different incretin hormones produced in the human gut—glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Its primary mechanisms of action are to:

  • Stimulate the pancreatic release of insulin in response to food
  • Increase insulin sensitivity
  • Reduce sugar production in the liver
  • Slow down gastric emptying and the rate of digestion

Tirzepatide, the active ingredient in Mounjaro and Zepbound, slows down the rate at which food leaves the stomach, thus helping patients fill up more quickly and feel fuller for longer. It also targets areas of the brain that regulate appetite, helping to reduce hunger and minimize cravings.

Tirzepatide is not approved for weight loss under the name Mounjaro but was recently approved for weight loss under the brand name Zepbound.

Mounjaro mimics two incretin hormones produced in your gut and activates their pathways throughout the body. It triggers endocrine and physiological responses that lower blood sugar levels in response to food, reducing hunger and cravings.

Mounjaro starts working in the body immediately. That being said, while some patients will notice its effects right away, others may need to reach a higher maintenance dose over a series of weeks to feel its impacts. Data from the SURPASS-2 and SURPASS-3 clinical trials indicates that tirzepatide (Mounjaro’s active ingredient) helps patients reach A1C targets more rapidly than Ozempic (semaglutide) or titrated insulin Tresiba (degludec).

Comparing Mounjaro

No. Mounjaro and Ozempic are two different drugs. While they are both injectable anti-diabetic medications that work similarly in the body, here are some key differences between them:

  • Mounjaro is manufactured by Eli Lilly, while Ozempic is manufactured by Novo Nordisk.
  • Mounjaro’s active ingredient is tirzepatide, while Ozempic’s is semaglutide.
  • Ozempic is classed as a GLP-1 receptor agonist, while Mounjaro is classed as both a GLP-1 receptor agonist and a GIP receptor agonist.
  • Ozempic lowers blood sugar levels in adults with Type 2 Diabetes and also reduces the risk of major adverse cardiovascular events in patients with Type 2 Diabetes and established heart disease. Currently, Mounjaro is only approved for controlling blood sugar levels in adults with Type 2 Diabetes.

Mounjaro is not currently approved for chronic weight management, but tirzepatide was recently FDA-approved for weight loss under the name Zepbound. Clinical trials have demonstrated that tirzepatide can promote weight loss of up to 20% or more in combination with a healthy diet and regular exercise. This surpasses other weight loss medications and approaches the outcomes associated with some weight loss surgeries.

Mounjaro and Zepbound are both injectable tirzepatide drugs manufactured by Eli Lilly. While they have the same chemical composition, the two medications are branded differently and indicated for different purposes: Mounjaro is indicated for the treatment of Type 2 Diabetes, while Zepbound is indicated for weight loss and chronic weight management.

Clinical Trials and Research

In tirzepatide clinical trials, the following outcomes contributed to the FDA’s approval of Mounjaro for blood sugar control and Zepbound for chronic weight management:

It is not yet determined whether Mounjaro lowers cardiovascular risks, but research in this area is currently underway (the SURMOUNT-MMO clinical trial will be completed in 2027). Wegovy, a similar drug, has been associated with cardiovascular risk reduction in obese patients, so there is a distinct possibility that the same may be true for Mounjaro (and Zepbound).

Availability and Access

Yes, you can order Mounjaro online, but be sure to verify the reputation of the online pharmacy or prescription referral service you are ordering from. Look for:

  • Valid prescriptions required
  • A verifiable address or phone number
  • A licensed pharmacist who is available to answer your questions

Yes, Mounjaro has been available in the U.S. since 2022. Zepbound is expected to also be available before the end of 2023.

Mounjaro has experienced shortages over the past year due to high demand. Eli Lilly reports that it is working to increase production capacity, particularly as Zepbound also hits the market.

Dosage and Administration

Mounjaro must be injected once weekly under the skin of the thigh, abdomen, or upper arm. It should be taken on the same day every week but can be administered at any time of day, with or without food.

Your doctor will show you how to properly inject Mounjaro, and you can also refer to the drug’s package insert. Below, we’ve provided a brief overview of the steps to follow when injecting Mounjaro:

  • Choose your injection site; rotating the site each week is recommended.
  • Visually inspect the Mounjaro pen to ensure the liquid appears clear and free of any sediment.
  • Remove the gray cap from the base of the pen.
  • Place the clear base on the injection site and press, then hold it in place for 10 seconds.
  • Safely dispose of the Mounjaro pen in an FDA-cleared sharps container and in compliance with all local rules and regulations.

Taking too much Mounjaro can lead to serious side effects. If you have accidentally taken more than your prescribed dose of the drug, contact your doctor for advice. If you are experiencing severe symptoms, seek emergency medical care immediately.

If you miss a dose of Mounjaro, take the dose as soon as you remember, as long as no more than 4 days have passed. If more than 4 days have passed since your missed dose, simply skip the dose and take your next dose of Mounjaro as scheduled.

Never inject a double dose of Mounjaro to make up for a missed dose, as this can lead to serious side effects. If you miss more than one dose of Mounjaro, contact your doctor to determine if a dosage adjustment may be required for restarting the medication.

No. Mounjaro pens should never be shared between patients under any circumstances. Sharing a Mounjaro pen, even if the needle has been replaced, can potentially lead to cross-contamination and the transfer of serious infections or diseases.

Mounjaro is only available as a liquid solution in single-dose injection pens. It must be injected subcutaneously and is available in the following doses:

  • 2.5 mg/0.5 mL
  • 5 mg/0.5 mL
  • 7.5 mg/0.5 mL
  • 10 mg/0.5 mL
  • 12.5 mg/0.5 mL
  • 15 mg/0.5 mL

The recommended maintenance doses for Mounjaro are 5 mg, 10 mg, or 15 mg.

Your doctor will determine how much Mounjaro you should take and when to increase your dose based on your body’s reaction to the drug. In most cases, Mounjaro’s dosing schedule is as follows:

  • 4 weeks at the 2.5 mg starting dose
  • 4 weeks at the 5 mg dose
  • Subsequent dose increases in 2.5 mg increments at 4-week intervals, as recommended by the supervising doctor
  • An effective maintenance dose of 5 mg, 10 mg, or 15 mg continues to be taken over the long term

Storage and Handling

The manufacturer recommends storing Mounjaro in the refrigerator between 36°F to 46°F (2°C to 8°C). Other recommendations include:

  • Keep Mounjaro in its original packaging to protect it from light.
  • Avoid dropping Mounjaro pens. If a pen has been dropped on a hard surface, dispose of it and use another pen.
  • Never allow Mounjaro to freeze; keep it away from the cooling element in your refrigerator and dispose of it if you suspect it has become partially or completely frozen.

As with any medication, always store Mounjaro out of the reach of children and pets.

Refrigerating Mounjaro is recommended and will help the medication last until its expiry date. That being said, Eli Lilly indicates that Mounjaro can last for up to 21 days unrefrigerated, if necessary.

In the event that you need to store Mounjaro unrefrigerated, be sure that its temperature does not exceed 86°F (30°C). Also, keep the medication in its original packaging to avoid exposure to light. Discard it after 21 days, even if the expiry date has not yet been reached.

Cost and Affordability

The manufacturer’s list price for Mounjaro is about $1,025 per four-week supply of the drug. However, the actual price you’ll pay for Mounjaro will depend on a variety of factors, including:

  • Whether or not you have insurance that covers Mounjaro
  • Whether or not you are eligible for any additional savings plans, such as the Mounjaro Savings Card
  • Where you purchase Mounjaro from
  • How much Mounjaro you purchase at a time

Ordering high-quality Canadian Mounjaro from Bisonpharmacy.com can drastically reduce your costs and allow you to access the drug affordably. For more information, contact our dedicated team directly today!

Side Effects

Mounjaro’s common side effects are typically most noticeable when first starting the drug or after titrating up to an increased dose but often resolve over time as the body adjusts. They can include:

  • Gastrointestinal issues such as nausea, diarrhea, constipation, vomiting, abdominal pain, indigestion, and decreased appetite
  • Injection site reactions
  • Fatigue

The manufacturer recommends mitigating gastrointestinal side effects by eating smaller meals, stopping eating when you feel full, consuming bland foods, and avoiding fatty foods. Staying upright after meals and getting plenty of fresh air may also be helpful.

Mounjaro’s more serious side effects only occur in a small percentage of people and may only appear after a period of time on the drug. They can include:

  • Ongoing or severe digestive problems
  • Serious hypersensitivity (allergic reactions)
  • Pancreatitis (inflammation of the pancreas)
  • Severe hypoglycemia (usually only in combination with insulin or other anti-diabetic medications)
  • Vision changes (usually only in diabetic patients with a history of diabetic retinopathy)
  • Gallbladder problems
  • Kidney problems (including acute kidney injury)
  • The formation of thyroid tumors
  • Suicidal ideation

If you experience any serious side effects while taking Mounjaro, contact your healthcare provider or seek emergency medical attention immediately. Your doctor might recommend discontinuing Mounjaro and finding an alternative treatment option.

Usage Duration

As a treatment for Type 2 Diabetes, a chronic disease, Mounjaro is meant to be a long-term medication. As long as it remains effective and you don’t experience any serious side effects while on it, Mounjaro can be taken indefinitely.

The impacts of Mounjaro on the body will subside once you stop taking it, so it’s vital to speak with your doctor before stopping Mounjaro injections. After creating an alternative treatment plan, you should be able to safely stop Mounjaro at any point in time.

Support and Contraindication

Mounjaro is prescribed and recommended by doctors and healthcare professionals across the U.S., and your doctor will be your best resource for learning more about the drug.

Other resources are also available, including:

Mounjaro is contraindicated for:

  • Patients who have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Type 2 (MEN 2)
  • Patients who have known allergies to tirzepatide or any of the other ingredients in Mounjaro
  • Patients who are under the age of 18
  • Patients who have Type 1 Diabetes
  • Patients who are already taking GLP-1 receptor agonist drugs

Speak to your doctor before taking Mounjaro if:

  • You have a history of pancreatitis, gallbladder or kidney issues, depression, or severe gastrointestinal disease
  • You are pregnant, breastfeeding, or trying to become pregnant
  • You are taking oral medications
  • You are taking insulin or other anti-diabetic medications

About the Author

Ida Edlweiss Gumpal is a licensed Pharmacist and medical writer. She took her internships at Mercury Drug Corporation, Inc., a Hospital internship at De Vera Medical Center, Inc., and a Manufacturing internship at Philmed Laboratories, Inc. She has plans on attending medical school with the goal of specializing in Neurosurgery or Cardiothoracic surgery.

Campaign for Personal Prescription Importation

Millions of Americans use licensed Canadian pharmacies annually, to purchase their daily prescription medications at an affordable price. We believe that all Americans have a right to affordable medications.